Nutriband, Inc. (NTRB)
7.28
-0.08
(-1.09%)
USD |
NASDAQ |
Oct 02, 16:00
7.50
+0.22
(+3.02%)
After-Hours: 20:00
Nutriband EPS Diluted (Quarterly) : -0.0724 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.0724 |
| April 30, 2026 | -0.1022 |
| January 31, 2026 | -0.0796 |
| October 31, 2025 | -0.3212 |
| July 31, 2025 | -2.123 |
| April 30, 2025 | -0.1248 |
| January 31, 2025 | -0.4981 |
| October 31, 2024 | -0.1227 |
| July 31, 2024 | -0.1542 |
| April 30, 2024 | -0.2072 |
| January 31, 2024 | -0.2295 |
| October 31, 2023 | -0.2247 |
| July 31, 2023 | -0.1058 |
| April 30, 2023 | -0.1296 |
| January 31, 2023 | -0.2144 |
| October 31, 2022 | -0.1378 |
| July 31, 2022 | -0.1059 |
| April 30, 2022 | -0.0751 |
| January 31, 2022 | -0.4118 |
| October 31, 2021 | -0.233 |
| July 31, 2021 | -0.0701 |
| April 30, 2021 | -0.0427 |
| Date | Value |
|---|---|
| January 31, 2021 | -0.3085 |
| October 31, 2020 | -0.0065 |
| July 31, 2020 | -0.0351 |
| April 30, 2020 | -0.0646 |
| January 31, 2020 | -0.1492 |
| October 31, 2019 | -0.119 |
| July 31, 2019 | -0.0712 |
| April 30, 2019 | -0.0906 |
| January 31, 2019 | -0.0815 |
| October 31, 2018 | -0.0768 |
| July 31, 2018 | -0.3033 |
| April 30, 2018 | -0.0686 |
| January 31, 2018 | -0.40 |
| October 31, 2017 | -0.0343 |
| July 31, 2017 | -0.0163 |
| April 30, 2017 | -0.0079 |
| January 31, 2017 | -0.0056 |
| October 31, 2016 | -0.0049 |
| July 31, 2016 | -0.0059 |
| April 30, 2016 | -0.04 |
| January 31, 2016 | -0.0001 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8806M |
| Revenue (Quarterly) | 0.4375M |
| Total Expenses (Quarterly) | 1.318M |
| Enterprise Value | 85.29M |
| Gross Profit Margin (Quarterly) | 40.73% |
| Profit Margin (Quarterly) | -201.3% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -7.904 |